Global Recombinant Peptide Market By Product Type (Glucagon, Calcitonin) And By End-Users/Application (Oncology, Blood Disorders) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-986336
  • April 2021
  • Pharmaceuticals
  • 114 Pages

Report Preview

The global Recombinant Peptide market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Recombinant Peptide market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Recombinant Peptide market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Recombinant Peptide market.

Apart from this, the market research report also covers drivers and restraints for the global Recombinant Peptide market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Recombinant Peptide market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Recombinant Peptide market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

XYZ Market Strategic Analysis:
In 2019, the global XYZ market was valued at US$ xx Mn, and it is expected to reach at US$ xx Mn at a CAGR of xx% during 2020-2028.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Recombinant Peptide market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty. 
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Glucagon, Calcitonin, Other
Applications Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Sandoz Pharma, Stada Arzneimittel, Amgen, Hospira, Actavis, Cipla Ltd., Wockhardt Ltd., Biocon Ltd.

Recombinant Peptide Market Segment Analysis:
The Recombinant Peptide market research report segments the market based on its types, applications and end-use industry. All the segments of the market are analyzed and evaluated based on current and future trends of the market. The data for the segments and its categories is provided from 2018 to 2028. 

Recombinant Peptide Market, by Type: Glucagon, Calcitonin, Other

Recombinant Peptide Market, by Application: Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, Other

Major Key Players for Global Recombinant Peptide Market:
The Recombinant Peptide market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Sandoz Pharma, Stada Arzneimittel, Amgen, Hospira, Actavis, Cipla Ltd., Wockhardt Ltd., Biocon Ltd.

Geographic Coverage for Recombinant Peptide Market:
The market research report on global Recombinant Peptide market offers complete analysis across various regions across the world. The Recombinant Peptide market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Recombinant Peptide market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Recombinant Peptide Market Value and Forecast
  • US
  • Canada

Europe Recombinant Peptide Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe

Asia Pacific Recombinant Peptide Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Recombinant Peptide Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Recombinant Peptide Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Key highlights of the Recombinant Peptide market report:
  • The report provides key trends of the global Recombinant Peptide market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Recombinant Peptide industry
  • The report covers all the recent developments of the Recombinant Peptide market and helps to provide current industry updates
  • The report covers a detailed look over the global Recombinant Peptide Industry and provides with significant actionable insights
  • The Recombinant Peptide market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Recombinant Peptide market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Recombinant Peptide market
  • Comprehensive analysis of the Recombinant Peptide market segments based on its types, applications and end-use industry

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Recombinant Peptide market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Recombinant Peptide market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Recombinant Peptide market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Recombinant Peptide market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Recombinant Peptide market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Recombinant Peptide Market Snapshot
          2.1.1. Global Recombinant Peptide Market By Type,2019
               2.1.1.1.Glucagon
               2.1.1.2.Calcitonin
               2.1.1.3.Other
          2.1.2. Global Recombinant Peptide Market By Application,2019
               2.1.2.1.Oncology
               2.1.2.2.Blood Disorders
               2.1.2.3.Infectious Diseases
               2.1.2.4.Autoimmune Diseases
               2.1.2.5.Other
          2.1.3. Global Recombinant Peptide Market By End-use,2019
          2.1.4. Global Recombinant Peptide Market By Geography,2019

3. Global Recombinant Peptide Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Recombinant Peptide Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Recombinant Peptide Market Size (US$), By Type, 2018 – 2028

5. Global Recombinant Peptide Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Recombinant Peptide Market Size (US$), By Application, 2018 – 2028

6. Global Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028

7. Global Recombinant Peptide Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Recombinant Peptide Market Analysis, 2018 – 2028 
          7.2.1. North America Recombinant Peptide Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Recombinant Peptide Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Recombinant Peptide Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Recombinant Peptide Market Analysis, 2018 – 2028 
          7.3.1.  Europe Recombinant Peptide Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Recombinant Peptide Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Recombinant Peptide Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Recombinant Peptide Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Recombinant Peptide Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Recombinant Peptide Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Recombinant Peptide Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Recombinant Peptide Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Recombinant Peptide Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Recombinant Peptide Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Recombinant Peptide Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Recombinant Peptide Market Analysis, 2018 – 2028 
          7.6.1.  MEA Recombinant Peptide Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Recombinant Peptide Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Recombinant Peptide Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Recombinant Peptide Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Recombinant Peptide Providers
        8.4.1 Sandoz Pharma
                8.1.1 Business Description
                8.1.2 Sandoz Pharma Geographic Operations
                8.1.3 Sandoz Pharma Financial Information
                8.1.4 Sandoz Pharma Product Positions/Portfolio
                8.1.5 Sandoz Pharma Key Developments
        8.4.2 Stada Arzneimittel
                8.2.1 Business Description
                8.2.2 Stada Arzneimittel Geographic Operations
                8.2.3 Stada Arzneimittel Financial Information
                8.2.4 Stada Arzneimittel Product Positions/Portfolio
                8.2.5 Stada Arzneimittel Key Developments
        8.4.3 Amgen
                8.3.1 Business Description
                8.3.2 Amgen Geographic Operations
                8.3.3 Amgen Financial Information
                8.3.4 Amgen Product Positions/Portfolio
                8.3.5 Amgen Key Developments
        8.4.4 Hospira
                8.4.1 Business Description
                8.4.2 Hospira Geographic Operations
                8.4.3 Hospira Financial Information
                8.4.4 Hospira Product Positions/Portfolio
                8.4.5 Hospira Key Developments
        8.4.5 Actavis
                8.5.1 Business Description
                8.5.2 Actavis Geographic Operations
                8.5.3 Actavis Financial Information
                8.5.4 Actavis Product Positions/Portfolio
                8.5.5 Actavis Key Developments
        8.4.6 Cipla Ltd.
                8.6.1 Business Description
                8.6.2 Cipla Ltd. Geographic Operations
                8.6.3 Cipla Ltd. Financial Information
                8.6.4 Cipla Ltd. Product Positions/Portfolio
                8.6.5 Cipla Ltd. Key Developments
        8.4.7 Wockhardt Ltd.
                8.7.1 Business Description
                8.7.2 Wockhardt Ltd. Geographic Operations
                8.7.3 Wockhardt Ltd. Financial Information
                8.7.4 Wockhardt Ltd. Product Positions/Portfolio
                8.7.5 Wockhardt Ltd. Key Developments
        8.4.8 Biocon Ltd.
                8.8.1 Business Description
                8.8.2 Biocon Ltd. Geographic Operations
                8.8.3 Biocon Ltd. Financial Information
                8.8.4 Biocon Ltd. Product Positions/Portfolio
                8.8.5 Biocon Ltd. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Recombinant Peptide Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Recombinant Peptide Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Recombinant Peptide Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Recombinant Peptide Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Recombinant Peptide Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Recombinant Peptide Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Recombinant Peptide Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Recombinant Peptide Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Recombinant Peptide Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Recombinant Peptide Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Recombinant Peptide Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Recombinant Peptide Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Recombinant Peptide Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Recombinant Peptide Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Recombinant Peptide Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Recombinant Peptide Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Recombinant Peptide: Market Segmentation 
FIG. 2 Global Recombinant Peptide Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Recombinant Peptide Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Recombinant Peptide Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Recombinant Peptide Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Recombinant Peptide Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Recombinant Peptide Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Recombinant Peptide Providers, 2019
FIG. 11 Global Recombinant Peptide Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Recombinant Peptide Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Recombinant Peptide Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Recombinant Peptide Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Recombinant Peptide Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Recombinant Peptide Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Recombinant Peptide Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Recombinant Peptide Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Recombinant Peptide market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Recombinant Peptide Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Recombinant Peptide Market Value, By Segment1, 2018 – 2028
TABLE  North America Recombinant Peptide Market Value, By Segment2, 2018 – 2028
TABLE  North America Recombinant Peptide Market Value, By Country, 2018 – 2028
TABLE  Europe Recombinant Peptide Market Value, By Segment1, 2018 – 2028
TABLE  Europe Recombinant Peptide Market Value, By Segment2, 2018 – 2028
TABLE  Europe Recombinant Peptide Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Recombinant Peptide Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Recombinant Peptide Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Recombinant Peptide Market Value, By Country, 2018 – 2028
TABLE  Latin America Recombinant Peptide Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Recombinant Peptide Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Recombinant Peptide Market Value, By Country, 2018 – 2028
TABLE  MEA Recombinant Peptide Market Value, By Segment1, 2018 – 2028
TABLE  MEA Recombinant Peptide Market Value, By Segment2, 2018 – 2028
TABLE  MEA Recombinant Peptide Market Value, By Country, 2018 – 2028
TABLE  Sandoz Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stada Arzneimittel: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hospira: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Actavis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wockhardt Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Recombinant Peptide Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Recombinant Peptide Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Recombinant Peptide Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Recombinant Peptide Market, By Geography, 2019 (US$ Mn)
FIG.  Global Recombinant Peptide Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Recombinant Peptide Providers, 2016
FIG.  Global Recombinant Peptide Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Glucagon Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Calcitonin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Peptide Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Oncology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Blood Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Infectious Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Autoimmune Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Recombinant Peptide Market Value, 2018 – 2028, (US$ Mn)